Thus, once-weekly TPTD administration might decrease serum phosphate levels via the stimulation of FGF23 when vitamin D actions are insufficient to prevent its decrease, for instance, in the presence of vitamin D insufficiency/deficiency. This evidence concerns the gene FGF23 and vitamin D deficiency.